Pharmacological intervention for cognitive deficits and aggression in frontal lobe injury

NeuroRehabilitation

Volumn 21, Issue 1, 2006, Pages 3-7

  Sugden, Steven G ^a   Kile, Shawn J ^a   Farrimond, Derald D ^a   Hilty, Donald M ^a   Bourgeois, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aggression; Amantadine; Donepezil; Frontal lobe syndrome; Traumatic brain injury; Valproate

Indexed keywords

AMANTADINE; DONEPEZIL; HALOPERIDOL; MIDAZOLAM; MORPHINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE;

ADULT; AGGRESSION; AGITATION; ALCOHOL BLOOD LEVEL; ALCOHOLISM; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE REHABILITATION; DELIRIUM; DIAGNOSTIC IMAGING; DRUG DEPENDENCE; ELECTROENCEPHALOGRAM; FRONTAL LOBE; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; HYPOTHERMIA; MALE; MULTIPLE TRAUMA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOTHORAX; PSYCHOPATHY; RESTLESSNESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TACHYCARDIA; THORAX RADIOGRAPHY; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY;

EID: 33646716627     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2006-21102     Document Type: Article

References (29)

1. S. Andersson, J. Berstad, A. Finset et al., Amantadine in cognitive failure in patients with traumatic head injuries, Tidsskrift for den Norsk Lageforening 112 (1992), 2070-2072.
2. D. Arcieniegas, L. Adler, J. Topkoff et al., Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating and a hypothesis for further investigation, Brain Inj 13 (1999), 1-13.
3. R.K. Bode and A.W. Heinemann, Course of functional improvement after stroke, spinal cord injury, and traumatic brain injury, Arch Phys Med Rehabil 83 (2002), 100-106.
4. D.D. Cardenas, A. McLean, L. Farrell-Roberts et al., Oral physostigmine and impaired memory in adults with brain injury, Brain Inj 8 (1994), 579-587.
5. V. Calatayud-Maldonando, J.B. Calatayud-Perez and J. Aso-Escario, Effects of CDP-choline on the recovery of patients with head injury, J Neurobiol Sci 103 (1991), S15-S18.
6. J.R. Fann, J.M. Uomoto and W.J. Katon, Cognitive improvement with treatment of depression following mild traumatic brain injury, Psychosomatics 42 (2001), 48-54.
7. T.A.Gennarelli, Cerebral concussion and diffuse brain injuries, in: Head Injury, (Vol. 2), P.K. Cooper, ed., Williams and Wilkins, Baltimore, 1987, pp. 108-124.
8. T.A. Gennarelli and D.I. Graham, Neuropathology of the head injuries, Semin Clin Neuropsychiatry 3 (1998), 73-81.
9. L.B. Goldstein, Neuropharmacology of TBI-induced plasticity, Brain Injury 17 (2003), 685-694.
10. T. Gualtieri, M. Chandler, T.B. Coons et al, Amantadine: a new clinical profile for traumatic brain injury, Clin Neuropharmacol 12 (1989), 258-270.
11. M.F. Kraus and P.M. Maki, Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review, J Neuropsychiatry Clin Neurosci 9 (1997), 222-230.
12. J.P. Lindenmayer and A. Kotsaftis, Use of sodium valproate in violent and aggressive behaviors: a critical review, J Clin Psychiatry 61 (2000), 123-128.
13. L.F. Marshall, Head injury: recent past, present, and future, Neurosurgery 47 (2000), 546-561.
14. J.M. Meythaler, R.C. Brunner, A. Johnson et al., Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial, J Head Trauma Rehabil 17 (2002), 300-313.
15. P.M. Plenger, E. Dixon, R.M. Castillo et al., Subacute Methylphenidate Treatment for Moderate to Moderately Severe Traumatic Brain Injury: A Preliminary Double-Blind Placebo-Controlled Study, Arch Phys Med Rehabil 77 (1996), 536-540.
16. V. Rao and C.G. Lyketsos, Neuropsychiatrie sequelae of traumatic brain injury, Psychosomatics 41 (2000), 95-103.
17. V. Rao and C.G. Lyketsos, Psychiatric aspects of traumatic brain injury, Psychiatr Clin North Am 25 (2002), 43-69.
18. W.R. Russell and A. Smith, Posttraumatic amnesia in closed head injury, Arch Neurol 5 (1961), 16-29.
19. Q. Schultz, P. Dayan and P.R. Montague, A neural substrate of prediction and reward, Science 275 (1997), 1593-1599.
20. O. Tenovuo, Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients, Prog Neuropsychopharmacol Biol Psychiatry 29 (2005), 61-67.
21. H.M. Van Pragg, G.M. Asnis, R.D. Kahn et al., Monoamines and abnormal behavior: a multi-aminergic perspective, Br J Psychiatry 157 (1990), 723-734.
22. J. van der Naalt, A.H. van Zomeren, W.J. Sluiter et al., One year outcome in mild to moderate head injury: the predictive value of acute injury characteristics related to complaints and return to work, J Neurol Neurosurg Psychiatry 66 (1999), 207-213.
23. R. Van Reekum, M. Baylery, S. Garner et al., N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury, Brain Injury 9 (1995), 49-53.
24. F.J. Whelan, M. Sullivan-Walker and S.K. Schultz, Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury, Ann Clin Psychiatry 12 (2000), 131-135.
25. J.A. Whitlock, Brain injury, cognitive impairment, and donepezil, J Head Trauma Rehabil 14 (1999), 424-427.
26. J.A. Whitlock and B.B. Hamilton, Functional outcome after rehabilitation for severe brain injury, Arch Phys Med Rehabil 76 (1995), 1103-1112.
27. J. Whyte, D. Cifu, S. Dikmen et al., Prediction of functional outcomes after traumatic brain injury: a comparison of 2 measures of duration of unconsciousness, Arch Phys Med Rehabil 82 (2001), 1355-1359.
28. J.T. Whyte, M. Hart, P. Vaccaro et al., Effects of Methylphenidate on Attention Deficits after Traumatic Brain Injury: A Multidimensional Randomized Controlled Trial, Am J Phys Med Rehabil 83 (2004), 401-420.
29. L. Zhang, R.C. Plotkin, G. Wang et al., Cholinergic augmentation with donepezil enhances recovery in short-tern memory and sustained attention after traumatic brain injury, Arch Phys Med Rehabil 85 (2004), 1050-1055.